Seeking Alpha
View as an RSS Feed

Stock Reversals  

View Stock Reversals' Comments BY TICKER:
Latest  |  Highest rated
  • Concert Pharmaceuticals: The Deuterated Drug Platform, A Profitable Way To Reinvent The Wheel [View article]
    one of our favorites
    Apr 18, 2015. 10:45 AM | 3 Likes Like |Link to Comment
  • Celladon's Cardiovascular Fast Track MYDICAR Candidate Could Provide Upside [View article]
    As in full FDA approval, they could give conditional use approval with safety studies ongoing
    Apr 3, 2015. 05:34 PM | Likes Like |Link to Comment
  • Celladon's Cardiovascular Fast Track MYDICAR Candidate Could Provide Upside [View article]
    FDA approval, we dont mean phase2b data hitting... we mean FDA approval, that could be another 12-18 months etc...
    Apr 2, 2015. 09:43 PM | Likes Like |Link to Comment
  • Celladon: The Next Breakthrough In Cardiovascular Gene Therapy? [View article]
    NO, our plan all along was load up at 16-18, then sell at 21-23 if it got there 1/2 of the position before MYDICAR. Then ROTH Came out with a $70 target and all heck broke loose, we sold at 26-27 at our service in that March 12-13 window 1/2. We held 1/2 and that is our plan holding that 1/2 into MYDICAR data...
    Mar 31, 2015. 04:09 PM | 2 Likes Like |Link to Comment
  • Celladon: The Next Breakthrough In Cardiovascular Gene Therapy? [View article]
    yep...we wrote this up at 17 in January. Sold half at 26...holding rest
    Mar 31, 2015. 08:49 AM | 3 Likes Like |Link to Comment
  • Trevena's Q4 2014 Results Conference Call - What We Learned [View article]
    We continue to like this one long term, our report came out March 12th at 5.75... nice pullback this week, it got pretty overheated with retail chasers... slow and steady wins the race...
    Mar 28, 2015. 12:30 PM | Likes Like |Link to Comment
  • Celladon's Cardiovascular Fast Track MYDICAR Candidate Could Provide Upside [View article]
    Retail traders set stop losses and then the computers run them often... at our SRP service we advised our members to sell 1/2 their CLDN at 26-27 about 2 weeks ago during the huge run up after Roth put that fat target on the shares. We had been buying from 16-18.... so we are long 1/2 now into MYDICAR data... this is really the best way to play these data related stocks. That said, we feel good about the upside here... but we never bet the farm on one stock...
    Mar 27, 2015. 04:30 PM | 1 Like Like |Link to Comment
  • T2 Biosystems: Impressive Opportunity With Sepsis Diagnosis [View article]
    already long at SRP I wrote a full report 2 weeks ago.
    Mar 26, 2015. 10:11 AM | 2 Likes Like |Link to Comment
  • Celladon's Cardiovascular Fast Track MYDICAR Candidate Could Provide Upside [View article]
    80... at least
    Mar 24, 2015. 10:41 PM | 2 Likes Like |Link to Comment
  • Celladon's Cardiovascular Fast Track MYDICAR Candidate Could Provide Upside [View article]
    No worries we as you know are long from much lower levels and our target was $80 upon approval, $35 plus if MYDICAR data hits...
    Mar 24, 2015. 03:23 PM | Likes Like |Link to Comment
  • Trevena's Q4 2014 Results Conference Call - What We Learned [View article]
    Here is our work from March 12th
    http://seekingalpha.co...

    We sent it to our SRP members and also SR members as well same morning, but posted it on our insta blog since we made it available to the free members and the public.
    Mar 23, 2015. 07:34 PM | Likes Like |Link to Comment
  • Celladon's Cardiovascular Fast Track MYDICAR Candidate Could Provide Upside [View article]
    Analysts are using 36,000 in their models not 75,000. Also , its a single dose and penetration would take quite some time. Nonetheless, we remain bullish
    Mar 23, 2015. 07:28 PM | Likes Like |Link to Comment
  • Trevena's Q4 2014 Results Conference Call - What We Learned [View article]
    We wrote a full report on this company several days before your Seeking Alpha piece hit and we are long from about 5 75
    Mar 23, 2015. 03:31 PM | Likes Like |Link to Comment
  • Celladon's Cardiovascular Fast Track MYDICAR Candidate Could Provide Upside [View article]
    We sold 1/2 our position at our SRP service and held 1/2, so that is how we are playing it. We took 50% profits and will ride into MYDICAR.
    Mar 22, 2015. 09:02 PM | Likes Like |Link to Comment
  • Cellectis on deck for what should be a very strong IPO [View news story]
    We wrote up Cellectis for our subscribers in January but via the CMVLF symbol which basically buys you the french listed stock in US dollars. Issue being currency risk, but from our $26 report we are nearing $40 in US dollars just 2 months or so later ahead of the IPO. It was a great way to get long before the IPO. Those who did some digging would have noted the quiet IPO announcement, which didnt show up on major press release distribution. We plan to hold obviously at this point.
    Mar 21, 2015. 11:19 AM | Likes Like |Link to Comment
COMMENTS STATS
296 Comments
262 Likes